Issue 11/2025
Todorov 1, 2, I.Yunakova3,4, M.
1 SAGBAL „Dr. Shterev“ – Sofia
2 Burgas State University “Prof. dr. Asen Zlatarov” – Burgas
3 SBALAG „Maichin dom“ – Sofia
4 Bulgarian Association on Sterility and Reproductive Health
In vitro fertilization (IVF) is one of the most well-known and effective methods for treating infertility, but the financial burden of the procedure poses a significant challenge for many couples. The costs of in vitro treatment vary across different European countries, depending on economic conditions and access to public funding. This article analyzes not only the financial aspects of the procedure but also its long-term return on investment for society, such as social contributions and tax revenues from future individuals conceived through IVF. Despite the well-documented medical benefits, the financial dimensions of in vitro treatment remain a topic of discussion. The costs of IVF in Europe show significant differences, and public support for the procedures varies, with some countries partially or fully covering the expenses. Long-term studies indicate that children born through IVF represent future taxpayers, generating significant economic benefits for both the state and society as a whole. Supporting public funding for IVF treatment should be viewed as a strategic investment in the future of society.
Key words: In vitro fertilization (IVF), Financial costs, Public funding, Long-term return, Reproductive medicine.
Address for correspondence:
Yunakova, M.
SAGBAL „Dr. Shterev“ – Sofia
25-31, “Hristo Blagoev”, Str.
1330, Sofia